JP2017222671A5 - - Google Patents

Download PDF

Info

Publication number
JP2017222671A5
JP2017222671A5 JP2017130471A JP2017130471A JP2017222671A5 JP 2017222671 A5 JP2017222671 A5 JP 2017222671A5 JP 2017130471 A JP2017130471 A JP 2017130471A JP 2017130471 A JP2017130471 A JP 2017130471A JP 2017222671 A5 JP2017222671 A5 JP 2017222671A5
Authority
JP
Japan
Prior art keywords
compound
conjugate
protein
immunogenic carrier
ovalbumin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017130471A
Other languages
English (en)
Japanese (ja)
Other versions
JP6423490B2 (ja
JP2017222671A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017222671A publication Critical patent/JP2017222671A/ja
Publication of JP2017222671A5 publication Critical patent/JP2017222671A5/ja
Application granted granted Critical
Publication of JP6423490B2 publication Critical patent/JP6423490B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017130471A 2012-08-21 2017-07-03 オランザピン(Olanzipine)のハプテン Active JP6423490B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261691454P 2012-08-21 2012-08-21
US61/691,454 2012-08-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015528568A Division JP6171014B2 (ja) 2012-08-21 2013-08-20 オランザピン(Olanzipine)のハプテン

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018196525A Division JP6763000B2 (ja) 2012-08-21 2018-10-18 オランザピン(Olanzipine)のハプテン

Publications (3)

Publication Number Publication Date
JP2017222671A JP2017222671A (ja) 2017-12-21
JP2017222671A5 true JP2017222671A5 (enExample) 2018-02-22
JP6423490B2 JP6423490B2 (ja) 2018-11-14

Family

ID=49081007

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015528568A Active JP6171014B2 (ja) 2012-08-21 2013-08-20 オランザピン(Olanzipine)のハプテン
JP2017130471A Active JP6423490B2 (ja) 2012-08-21 2017-07-03 オランザピン(Olanzipine)のハプテン
JP2018196525A Active JP6763000B2 (ja) 2012-08-21 2018-10-18 オランザピン(Olanzipine)のハプテン

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2015528568A Active JP6171014B2 (ja) 2012-08-21 2013-08-20 オランザピン(Olanzipine)のハプテン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018196525A Active JP6763000B2 (ja) 2012-08-21 2018-10-18 オランザピン(Olanzipine)のハプテン

Country Status (11)

Country Link
US (1) US9303041B2 (enExample)
EP (2) EP3492473B1 (enExample)
JP (3) JP6171014B2 (enExample)
CN (1) CN104854110B (enExample)
AU (1) AU2013306018B2 (enExample)
CA (1) CA2882454C (enExample)
ES (2) ES2701062T3 (enExample)
PL (1) PL2888269T3 (enExample)
PT (1) PT2888269T (enExample)
TR (1) TR201816378T4 (enExample)
WO (1) WO2014031587A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2888285B1 (en) 2012-08-21 2024-04-17 Janssen Pharmaceutica NV Antibodies to aripiprazole haptens and use thereof
WO2014031648A2 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc Antibodies to risperidone and use thereof
CA2882562C (en) 2012-08-21 2019-08-27 Eric Hryhorenko Antibodies to aripiprazole and use thereof
US9494608B2 (en) 2012-08-21 2016-11-15 Janssen Pharmaceutica Nv Antibodies to olanzapine and use thereof
TR201910347T4 (tr) 2012-08-21 2019-07-22 Janssen Pharmaceutica Nv Olanzapin haptenlerine yönelik antikorlar ve bunların kullanımı.
EP3385284B1 (en) 2012-08-21 2020-02-26 Janssen Pharmaceutica NV Antibodies to quetiapine haptens and use thereof
EP3333195B1 (en) 2012-08-21 2020-08-05 Janssen Pharmaceutica NV Antibodies to quetiapine and use thereof
HK1211958A1 (en) 2012-08-21 2016-06-03 Ortho-Clinical Diagnostics, Inc. Antibodies to paliperidone and use thereof
US20140057297A1 (en) 2012-08-21 2014-02-27 Janssen Pharmaceutica Nv Antibodies to Paliperidone Haptens and Use Thereof
CA2882563C (en) 2012-08-21 2022-11-29 Eric Hryhorenko Antibodies to risperidone haptens and use thereof
ES2652641T3 (es) 2012-08-21 2018-02-05 Janssen Pharmaceutica Nv Haptenos de aripiprazol y su uso en inmunoensayos
EP3492473B1 (en) * 2012-08-21 2025-07-30 Janssen Pharmaceutica NV Haptens of olanzapine
CA3008812A1 (en) 2015-12-17 2017-06-22 Janssen Pharmaceutica Nv Antibodies to quetiapine and use thereof
EP3390449A1 (en) 2015-12-17 2018-10-24 Janssen Pharmaceutica N.V. Antibodies to risperidone and use thereof
CN110950808A (zh) * 2019-10-30 2020-04-03 杭州博拓生物科技股份有限公司 一种氯氮平人工抗原及其制备方法
CN110938082A (zh) * 2019-10-30 2020-03-31 杭州博拓生物科技股份有限公司 一种奥氮平人工抗原及其制备方法
JP2023554137A (ja) * 2020-12-22 2023-12-26 インターベット インターナショナル ベー. フェー. マイコトキシン症から保護するためのコンジュゲート化ゼアラレノン
CN114685527B (zh) * 2020-12-25 2024-03-05 长沙博源医疗科技有限公司 一种奥氮平衍生物、免疫原、抗奥氮平特异性抗体及其制备方法与应用
CN114685477B (zh) * 2020-12-25 2023-11-17 长沙博源医疗科技有限公司 一种利奈唑胺衍生物、免疫原、抗利奈唑胺特异性抗体及其制备方法与应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022780A (en) 1973-03-06 1977-05-10 Imperial Chemical Industries Limited Process for the manufacture of indole derivatives
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
DK0582368T3 (da) * 1992-05-29 2001-02-05 Lilly Co Eli Thienobenzodiazepinderivater til behandling af forstyrrelser i centralnervesystemet
US6034078A (en) 1992-05-29 2000-03-07 Eli Lilly And Company Limited Thienobenzodiazepine compounds
ATE176329T1 (de) * 1992-06-26 1999-02-15 Johnson & Johnson Clin Diag Immunotests unter verwendung von markierten thyronin-analogen
US5395933A (en) * 1992-08-07 1995-03-07 Eastman Kodak Company Carbamazepine hapten analogues
UA76708C2 (uk) * 1999-12-08 2006-09-15 Сінгента Патисипейшонс Аг Антитіло, яке застосовується в імунологічному аналізі зразка для визначення неонікотиноїдного інсектициду, білковий кон'югат для одержання антитіла, спосіб визначення концентрації неонікотиноїдного інсектициду в зразку та набір для визначення кількості неонікотиноїдного інсектициду
US6958156B2 (en) 2000-12-15 2005-10-25 Vyrex Corporation Isoflavone derivatives
US7214673B2 (en) * 2002-03-28 2007-05-08 Eli Lilly And Company Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
DE60313634T2 (de) * 2002-08-05 2008-01-31 Eli Lilly And Co., Indianapolis Piperazinsubstituierte arylbenzodiazepine
DE602004024798D1 (de) * 2003-09-23 2010-02-04 Fermion Oy Herstellung von quetiapin
EP1789091B1 (en) * 2004-08-26 2010-08-25 Piramal Life Sciences Limited Prodrugs containing novel bio-cleavable linkers
TW200616604A (en) * 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
JP2010540920A (ja) * 2007-09-27 2010-12-24 ノバルティス アーゲー 薬物モニタリングアッセイ
WO2010033270A1 (en) 2008-09-17 2010-03-25 Auspex Pharmaceuticals, Inc. Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
JP5749169B2 (ja) 2008-10-14 2015-07-15 アストラゼネカ アクチボラグ 細菌感染の処置用の縮合スピロ環式ヘテロ芳香族化合物
EP2194048A1 (en) 2008-12-02 2010-06-09 Dirk Sartor Nitrate esters for the treatment of vascular and metabolic diseases
CA2785846C (en) 2009-12-31 2015-07-07 Kempharm, Inc. Amino acid conjugates of quetiapine, process for making and using the same
US8900604B2 (en) 2010-03-11 2014-12-02 Kempharm, Inc. Fatty acid conjugates of quetiapine, process for making and using the same
US8088594B2 (en) 2010-03-16 2012-01-03 Saladax Biomedical Inc. Risperidone immunoassay
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
US8623324B2 (en) 2010-07-21 2014-01-07 Aat Bioquest Inc. Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
JP5757497B2 (ja) * 2010-10-06 2015-07-29 公立大学法人大阪府立大学 シガトキシン類ctx1bおよび54−デオキシ−ctx1bを認識するモノクローナル抗体およびそれを用いるシガトキシン類検出キット
US8969337B2 (en) 2011-12-15 2015-03-03 Alkermes Pharma Ireland Limited Prodrugs of secondary amine compounds
EP3492473B1 (en) * 2012-08-21 2025-07-30 Janssen Pharmaceutica NV Haptens of olanzapine

Similar Documents

Publication Publication Date Title
JP2017222671A5 (enExample)
JP2015532645A5 (enExample)
JP2018184433A5 (enExample)
JP2015181191A5 (enExample)
JP2019524645A5 (enExample)
JP2017048194A5 (enExample)
JP2019194236A5 (enExample)
JP2021505614A5 (enExample)
JP2011511933A5 (enExample)
JP2016535744A5 (enExample)
JP2009120624A5 (enExample)
WO2018102315A8 (en) Polymorphs of sepiapterin and salts thereof
JP2013539454A5 (enExample)
JP2012001634A5 (enExample)
RU2019110152A (ru) Лекарственные средства на основе лантионинсинтетаза c-подобного белка 2
JP2014521346A5 (enExample)
CN110612292A (zh) 奥扎莫德加成盐晶型、制备方法及药物组合物和用途
WO2015107363A3 (en) Mycobacterial antigen composition
CO2017000010A2 (es) Proceso para la preparacion de ácidos 3-hidroxipicolínicos
JP2018502174A5 (enExample)
JP2012515709A5 (enExample)
RU2016107486A (ru) Способ получения рифаксимина к
WO2016114501A3 (ko) 대면적 단일 도메인으로 배열된 유기분자의 수직원기둥 또는 라멜라 구조체의 제조방법
MX393759B (es) Suspensiones inyectables
CN109476662A (zh) 一种jak1选择性抑制剂的新晶型及其制备方法和用途